Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders


Sector: Technology | Sub-Sector: Health Information Services
Alternate Symbol(s):  DGNOF

Diagnos Inc provides image analysis services through CARA (Computer Assisted Retinal Analysis), a software tool which assists health specialists in the detection of diabetic retinopathy.
Price: $0.07 Volume: 74,100
Change: $-0.005 % Change: -6.67%
Day High/Low: 0.07/0.07 52 Week High/Low: 0.11/0.035
Last Traded: September 04, 2015 10:50 Transaction Volume: 1000
Open: 0.07 Previous Close: 0.075
Bid: 0.07 Ask: 0.075
Bid Size: 1000 Ask Size: 31000
Market Cap: 7.4m Shares Out: 106.2m
PE Ratio: N/A Dividend Yield: N/A

Latest Bullboard Posts

  • RE:RE:Financing Update

    0 stars

    So what did the financing mean? On one hand, the $4 million target was not met. The $2.29 million was committed by July 30th and August...

    4.5 stars

  • RE:Financing Update

    0 stars

    2015-09-01 18:17 CT - Private Placement - Debenture The TSX Venture Exchange has accepted for filing the documentation with respect to a...

    4.5 stars

  • Financing Update

    0 stars

    2015-09-01 15:39 CT - News Release Mr. Marc-Andre Massue reports DIAGNOS ANNOUNCES CLOSING OF SECOND TRANCHE OF PRIVATE PLACEMENT Diagnos...

    4.5 stars

  • RE:This week

    0 stars

    looks like something's up... The additional options could be on the heels of advancements that are at the signing stage... or the...

    1.5 stars

  • This week

    0 stars

    Quite a week on the markets. Some rebound now. Diagnos only had room to grant 588,738 stock options. 8 million more are being added. This...

    4.5 stars